Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
substantial decrease » substantial increase (Expand Search), substantially increased (Expand Search)
decrease cell » decreased cell (Expand Search), increased cell (Expand Search), disease cell (Expand Search)
Showing 121 - 140 results of 49,998 for search '(( significant decrease cell ) OR ( significant ((substantial decrease) OR (small decrease)) ))', query time: 1.30s Refine Results
  1. 121
    Discovery of Natural Products Alleviating Renal Fibrosis with a Viscosity-Responsive Molecular Probe

    Discovery of Natural Products Alleviating Renal Fibrosis with a Viscosity-Responsive Molecular Probe by Kaiyu Zhang (198799)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  2. 122
    Utilization of anticoagulants at eight hospitals from 2019 to 2023.

    Utilization of anticoagulants at eight hospitals from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 123
    Discovery of Natural Products Alleviating Renal Fibrosis with a Viscosity-Responsive Molecular Probe

    Discovery of Natural Products Alleviating Renal Fibrosis with a Viscosity-Responsive Molecular Probe by Kaiyu Zhang (198799)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  4. 124
    Inpatient utilization of anticoagulants from 2019 to 2023.

    Inpatient utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 125
    Indications for warfarin prescription in outpatients and inpatients in 2023.

    Indications for warfarin prescription in outpatients and inpatients in 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 126
    Outpatient utilization of anticoagulants from 2019 to 2023.

    Outpatient utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 127
    DDC for four anticoagulants from 2019 to 2023.

    DDC for four anticoagulants from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 128
    Utilization of anticoagulants from 2019 to 2023.

    Utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 129
    The expenditure on anticoagulants in the period of 2019-2023(million CNY).

    The expenditure on anticoagulants in the period of 2019-2023(million CNY). by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 130
    Loss of Mod does not affect NB asymmetric cell division.

    Loss of Mod does not affect NB asymmetric cell division. by Amalia S. Parra (4173004)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 131
    Effect of protodioscin and dioscin on the antioxidant defense system of the adenocarcinoma MCF-7 and MDA-MB-468 cell lines.

    Effect of protodioscin and dioscin on the antioxidant defense system of the adenocarcinoma MCF-7 and MDA-MB-468 cell lines. by Najat Bouchmaa (13558816)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  12. 132
    Measuring results of Hela cells subjected to different durations of fluid shear stress by Atomic Force Microscopy (AFM)

    Measuring results of Hela cells subjected to different durations of fluid shear stress by Atomic Force Microscopy (AFM) by Xinyao Zhao (5824427)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 133
    Transepithelial resistance of NHBE decreases significantly after PAA exposure.

    Transepithelial resistance of NHBE decreases significantly after PAA exposure. by Ellie S. Burns (21246537)

    Published 2025
    Save to List
    Saved in:
  14. 134
    (A) HepG2-hNTCP were exposed to DMSO or different concentrations of Bexarotene (1 μM, 10 μM, and 20 μM) for 72 h; cell viability was then evaluated by XTT assay.

    (A) HepG2-hNTCP were exposed to DMSO or different concentrations of Bexarotene (1 μM, 10 μM, and 20 μM) for 72 h; cell viability was then evaluated by XTT assay. by Sameh A. Gad (12269979)

    Published 2022
    Save to List
    Saved in:
  15. 135
    Distribution of FcμR positive cells in ileum lymph nodes.

    Distribution of FcμR positive cells in ileum lymph nodes. by Xie Fei (6740372)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  16. 136
    Distribution of FcμR positive cells in duodenal lymph nodes.

    Distribution of FcμR positive cells in duodenal lymph nodes. by Xie Fei (6740372)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  17. 137
    Distribution of FcμR positive cells in jejunum lymph nodes.

    Distribution of FcμR positive cells in jejunum lymph nodes. by Xie Fei (6740372)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  18. 138
    Measuring the Young’s modulus of Hela cells subjected to different durations of fluid shear stress by Atomic Force Microscopy (AFM).

    Measuring the Young’s modulus of Hela cells subjected to different durations of fluid shear stress by Atomic Force Microscopy (AFM). by Xinyao Zhao (5824427)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 139
    miR-1247-3p was downregulated in CRC resistant cells.

    miR-1247-3p was downregulated in CRC resistant cells. by Dequan Wang (6007007)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 140
    Risk of fracture with competing risk in denosumab users versus non-users.

    Risk of fracture with competing risk in denosumab users versus non-users. by Arisa Kobayashi (4379608)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: